{"id":"W2081649373","doi":"10.1007/s10637-005-5860-y","title":"A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group","year":2005,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada); Jewish General Hospital; Hamilton Regional Laboratory Medicine Program; Ottawa Regional Cancer Foundation","funders":"","keywords":"Cancer; Medicine; Investigational Drugs; Drug; Cancer drugs; Family medicine; Gerontology; Internal medicine; Clinical trial; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001707711,0.002906749,0.004372895,0.0008453325,0.0006848984,0.001309382,0.001148047,0.001742103,0.005540175],"category_scores_gemma":[0.001494217,0.00102398,0.002090459,0.0007576622,0.001340779,0.001072424,0.0003741528,0.004835879,0.001690491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009713415,"about_ca_system_score_gemma":0.002042409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002014685,"about_ca_topic_score_gemma":0.004770187,"domain_scores_codex":[0.9995348,0.0002394167,0.00001806156,0.00006392996,0.00004398676,0.00009976823],"domain_scores_gemma":[0.9989473,0.0002059916,0.0001433923,0.0000872969,0.00005932184,0.0005567085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8218663,0.06527223,0.003528353,0.0008869732,0.001198088,0.0002895299,0.0002526314,0.00241223,0.02556969,0.0003796311,0.009664354,0.06867995],"study_design_scores_gemma":[0.7700303,0.2202482,0.005238994,0.00001806939,0.0003190977,0.0001767757,0.00004369281,0.0008814906,0.001219169,0.0001266058,0.001662283,0.00003538436],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852186,0.002398046,0.0006780874,0.001116458,0.0002923056,0.002495764,0.003641396,0.0002765887,0.003882798],"genre_scores_gemma":[0.9722748,0.004432375,0.00255535,0.001651902,0.0004404846,0.002742914,0.007138533,0.000116897,0.008646777],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005540175,"threshold_uncertainty_score":0.01853371,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1409265698095374,"score_gpt":0.4577079910447914,"score_spread":0.3167814212352541,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}